CAS 1130067-34-3

Cay10594

CAS : 1130067-34-3

Formule : C₂₆H₂₈N₄O₂

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 428.5261

Ref: IN-DA0078FZ

N-(2-(4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-8-Yl)Ethyl)-2-Naphthamide

CAS : 1130067-34-3

N-(2-(4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-8-Yl)Ethyl)-2-Naphthamide

Degré de pureté : 98+%

Masse moléculaire : 428.53g/mol

Ref: 54-OR1025649

CAY10594

CAS : 1130067-34-3

CAY10594

Degré de pureté : ≥95%

Masse moléculaire : 428.53g/mol

Ref: 54-BUP03923

CAY10594

CAS : 1130067-34-3

CAY10594, a PLD2 inhibitor, mitigates acetaminophen liver damage via the p-GSK-3β/JNK pathway.

Formule : C₂₆H₂₈N₄O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 428.53

Ref: TM-T7280

CAY10594

Produit contrôlé

CAS : 1130067-34-3

Formule : C₂₆H₂₈N₄O₂

Couleur et forme : Neat

Masse moléculaire : 428.526

Ref: TR-C227023

CAY10594

CAS : 1130067-34-3

CAY10594 is a small molecule that inhibits the activity of MMP-9 and blocks the inflammatory response in bowel disease. In vitro studies have shown that CAY10594 inhibits protein synthesis by blocking cation channels and reduces inflammation in an animal model. This drug has also been shown to inhibit the proliferation of cancer cells, including breast cancer cells, by blocking epidermal growth factor receptors. The effects of CAY10594 are mediated through its interaction with basic fibroblast growth factor, fatty acid binding protein, and epidermal growth factor receptor.

Formule : C₂₆H₂₈N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 428.53 g/mol

Ref: 3D-FVB06734